ARISTO BIO-TECH AN
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ARISTO BIO-TECH AN's past years’ income statements indicate that its last revenue has increased compared to the previous period by 47% to $2,451,480,000. The net income raised on $38,957,000 and profit margin reached 2%. Total operating expenses were $37,275,000.
Profit Margin
| 2021 | 1.67B | 10.75M | 0.64% |
|---|---|---|---|
| 2024 | 2.45B | 38.95M | 1.59% |
ARISTO-SM.NS Income Statement (2020 – 2023)
| 2023 | 2020 | |
|---|---|---|
Revenue | ||
Revenue | 2.45B | 1.67B |
Cost of revenue | 2.26B | 1.50B |
Gross profit | 191.10M | 170.65M |
Operating exp. | ||
Research and development | 0 | 0 |
Selling and marketing | 298K | 43K |
Total operating expenses | 37.27M | 133.70M |
Operating income | 153.82M | 35.94M |
Other income (expenses), net | -99.75M | -20.96M |
Income before tax | 54.07M | 14.98M |
Income tax expense | 15.11M | 4.22M |
Net income | 38.95M | 10.75M |
Earnings per share | ||
Basic EPS | 5.72 | 2.15 |
Diluted EPS | 5.72 | 2.15 |
| Data source | Data source |